Expected Rebound in Elective and Medically Necessary Procedures

Expected Rebound in Elective and Medically Necessary Procedures

Rafi Musher • May 26, 2020
Rafi Musher • May 26, 2020

Share

Stax's short term outlook (1-6 month) across the healthcare sector.

Many healthcare companies have similar questions about return to patient volumes, which locations will see a return to procedures, and the long-term prognosis for healthcare. To facilitate the process and speed up the effort, Stax has initiated new field research on expectations for return to procedures and developed a fast framework to help management teams, boards of directors, and investors determine the short, medium, and long- term implications for healthcare and their particular organizations.


The process is informed by 20 years of providing healthcare leaders with insights for strategic operating and investment decisions. It is inclusive, iterative, data-rich, and can be done remotely.


With a 20+ year record of successfully modeling healthcare volumes, supply and demand, and competitive market dynamics across the spectrum of providers, we know how public and private spend can be modeled to help forecast overall patient volumes nationally and locally. We have a range of traditional and creative datasets at our fingertips and understand how to conduct large-scale primary research with consumers, healthcare professionals, and providers. Healthcare choices are complex, and there is a tremendous amount of data to bring together and model to provide strong parameters on patient volumes and market share potential, for management teams and investors for the short and long term.




Contact Us

Read More

A Recap: Investing in Behavioral Health—Scalable Solutions for a Growing Need
July 14, 2025
Stax hosted healthcare-focused PE professionals in NYC to discuss a range of topics including scalable, tech-enabled behavioral health investments amid evolving care models and reimbursement. Click to learn more about what this event covered and how you can learn more.
Stax Perspective: AI Tools for K-12 Education
By Miriam El-Baz July 9, 2025
With AI education now a national priority, Miriam El-Baz highlights in her latest article how investor focus is shifting to classroom adoption and long-term, responsible impact. Learn more.
Stax Provides Sell-side Support to Bow River Capital on its Sale of Progressive Roofing to TopBuild
July 8, 2025
Stax congratulates Bow River Capital on the successful sale of Progressive Roofing, provider commercial roofing installation services, to TopBuild. Click here to read more.
A Plan in Need of a Plan—Early Reflections on the New 10-Year Plan for the NHS
By Adam Thorpe July 4, 2025
Following the release of the NHS 10-Year Plan yesterday, Stax explores what it means for independent sector providers and healthcare investors. Read more.
Featured by Reuters: How China's new auto giants left GM, VW and Tesla in the dust
By Phil Dunne July 3, 2025
In this recent Reuters special report, Phil Dunne highlights why automakers struggle to match Chinese carmakers—but still hold key advantages, especially in Europe. Click here to read more.
Featured by Carta: Tariffs bring uncertainty—and opportunities—for PE and M&A
By Robert Lytle July 2, 2025
Senior Managing Director Robert Lytle was featured by Carta in their latest article, discussing the impacts of tariffs on M&A and portfolio companies. Click here to read more.
Show More